Lanreotide Acetate CAS:127984-74-1
Diagnosis and Prescription: Lanreotide acetate is prescribed for patients diagnosed with neuroendocrine tumors or acromegaly. It is essential to follow the specific dosage and administration instructions provided by the healthcare provider. Injection Administration: Lanreotide acetate is typically administered via deep subcutaneous injection. The injection site may include the upper thigh, upper arm, or lower abdomen, as recommended by the healthcare professional. Dosage Schedule: The dosing frequency and amount of lanreotide acetate are individualized based on the patient's condition and response to treatment. Adhering to the prescribed schedule is crucial for optimizing therapeutic benefits. Monitoring and Adjustments: Health professionals closely monitor patients receiving lanreotide acetate, assessing its effectiveness and identifying any adverse effects. Dose adjustments might be necessary based on the patient's clinical status and tolerance. Storage and Handling: Proper storage and handling of lanreotide acetate are vital to maintain its stability and potency. It should be stored according to the manufacturer's recommendations and kept out of reach of children. Adverse Effects and Precautions: Patients need to be aware of potential side effects, such as gastrointestinal disturbances, injection site reactions, and changes in blood sugar levels. Additionally, individuals with known allergies or certain health conditions should inform their healthcare provider before initiating treatment. Healthcare Provider Collaboration: Close collaboration with healthcare providers is essential during lanreotide acetate therapy. Patients should report any new symptoms, concerns, or changes in their health status to their healthcare team. It is crucial to emphasize that lanreotide acetate must be used strictly under the guidance and supervision of a qualified healthcare professional. Patients should receive comprehensive information about the medication, including dosage, administration technique, potential side effects, and steps to take if adverse reactions occur. Any questions or uncertainties regarding lanreotide acetate use should be addressed with the prescribing physician or healthcare team.
Composition | C54H69N11O10S2 |
Assay | 99% |
Appearance | white powder |
CAS No. | 127984-74-1 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |